ENO1 and cancer: As a hub gene of signature identified by PPI network, ENO1 is overexpressed in 70% of human cancers and is associated with poor cancer prognosis, converts 2-phosphoglycerate to phosphoenolpyruvate, plays an important role in the glycolytic pathway and the Warburg effect in cancer cells [19, 20].